Muscle ultrasonography to predict survival in amyotrophic lateral sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 5, 2011, Pages 552-554

  Arts, Ilse Mp ^a   Overeem, Sebastiaan ^a   Pillen, Sigrid ^a   Jurgen Schelhaas, Helenius ^a   Zwarts, Machiel J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RILUZOLE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; ECHOGRAPHY; FEMALE; HUMAN; MALE; MUSCLE STRENGTH; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; SURVIVAL TIME; SYMPTOMATOLOGY;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 79953863919     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.200519     Document Type: Article

References (16)

1. Gordon PH, Moore DH, Miller RG, et al. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol 2007; 6: 1045-53. (Pubitemid 350116691)
2. Lacomblez L, Bensimon G, Leigh PN, et al. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996; 347: 1425-31. (Pubitemid 26161204)
3. Zoccolella S, Beghi E, Palagano G, et al. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2008; 79: 33-7.
4. de Carvalho M, Swash M. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis? Arch Neurol 2006; 63: 557-60.
5. Kimura F, Fujimura C, Ishida S, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 2006; 66: 265-7. (Pubitemid 43970171)
6. Kollewe K, Mauss U, Krampfl K, et al. ALSFRS-R score and its ratio: A useful predictor for ALS-progression. J Neurol Sci 2008; 275: 69-73.
7. Gordon PH, Cheng B, Montes J, et al. Outcome measures for early phase clinical trials. Amyotroph Lateral Scler 2007; 8: 270-3. (Pubitemid 47543091)
8. Pillen S, Arts IM, Zwarts MJ. Muscle ultrasound in neuromuscular disorders. Muscle Nerve 2008; 37: 679-93. (Pubitemid 351821895)
9. Arts IM, van Rooij FG, Overeem S, et al. Quantitative muscle ultrasonography in amyotrophic lateral sclerosis. Ultrasound Med Biol 2008; 34: 354-61. (Pubitemid 351635676)
10. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-9.
11. Pillen S, van Dijk JP, Weijers G, et al. Quantitative gray-scale analysis in skeletal muscle ultrasound: A comparison study of two ultrasound devices. Muscle Nerve. 2009; 39: 781-6.
12. Medical Research Council. Aids to the examination of the peripheral nervous system. London: HMSO, 1976.
13. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999; 169: 13-21. (Pubitemid 29502501)
14. Czaplinski A, Yen AA, Simpson EP, et al. Predictability of disease progression in amyotrophic lateral sclerosis. Muscle Nerve 2006; 34: 702-8. (Pubitemid 44883081)
15. Pillen S, Tak RO, Zwarts MJ, et al. Skeletal muscle ultrasound: correlation between fibrous tissue and echo intensity. Ultrasound Med Biol 2009; 35: 443-6.
16. Froes MM, Kristmundsdottir F, Mahon M, et al. Muscle morphometry in motor neuron disease. Neuropathol Appl Neurobiol 1987; 13: 405-19. (Pubitemid 18068140)